Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease

Abstract Aims Low-dose colchicine reduces cardiovascular risk in patients with coronary artery disease (CAD), but absolute benefits may vary between individuals. This study aimed to assess the range of individual absolute benefits from low-dose colchicine according to patient risk profile. Methods a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of preventive cardiology 2023-12, Vol.30 (18), p.1950-1962
Hauptverfasser:	Burger, Pascal M, Dorresteijn, Jannick A N, Fiolet, Aernoud T L, Koudstaal, Stefan, Eikelboom, John W, Nidorf, Stefan M, Thompson, Peter L, Cornel, Jan H, Budgeon, Charley A, Westendorp, Iris C D, Beelen, Driek P W, Martens, Fabrice M A C, Steg, Philippe Gabriel, Asselbergs, Folkert W, Cramer, Maarten J, Teraa, Martin, Bhatt, Deepak L, Visseren, Frank L J, Mosterd, Arend
Format:	Artikel
Sprache:	eng
Schlagworte:	Cholesterol, LDL Colchicine - adverse effects Coronary Artery Disease - diagnosis Coronary Artery Disease - drug therapy Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Myocardial Infarction - drug therapy Risk Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!